Group's fourth-quarter 2024 earnings report revealed a stark contrast between earnings per share (EPS) and revenue performance. The company, with a market capitalization of $768.53 million, reported ...

Moderna Inc . (BMV:MRNA) reported its fourth-quarter earnings for 2024, revealing a significant decline in revenue and a net loss. The company's earnings per share (EPS) were lower than expected, and ...

MS (MS Re), a global reinsurance provider, delivered strong financial growth in the first nine months of fiscal year 2024, driven by solid ...

Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...